A Study to Assess Safety and Efficacy of Centhaquine as a Resuscitative Agent

Clinical trial NCT05251181 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05251181
Sponsor: Pharmazz, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hypovolemic Shock

Start date: 2026-02-01
Primary completion: 2026-10-01
Enrollment: 430

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.